Dr. Nathavitharana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 Francis Street
Boston, MA 02215
Education & Training
- Imperial College London School of MedicineClass of 2007
Certifications & Licensure
- MA State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Testing Health Workers At Risk to Advance Our Understanding of TB Infection Start of enrollment: 2024 Jan 15
Roles: Principal Investigator
Publications & Presentations
PubMed
- Effects of Respiratory Isolation for Tuberculosis to Reduce Community-based Transmission: A Systematic Review.Ruvandhi R Nathavitharana, Abarna Pearl, Amanda Biewer, Laura Young, Leonard Mukasa
Clinical Infectious Diseases. 2025-02-05 - Assessing Infectiousness and the Impact of Effective Treatment to Guide Isolation Recommendations for People With Pulmonary Tuberculosis.Ruvandhi R Nathavitharana, Abarna Pearl, Amanda Biewer, Christie Tzelios, Sundari Mase
The Journal of Infectious Diseases. 2025-02-04 - Trajectories of interferon-gamma release assay results over two years in independent cohorts from China, South Africa, Tanzania, and the United States.Cheng Chen, Hao Xue, C Robert Horsburgh, Maryam Amour, Mark Hatherill
Chest. 2025-02-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: